- Home
- IPHA vs BZUN Comparison
IPHA vs BZUN Comparison
Compare IPHA & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- BZUN
- Stock Information
- Founded
- IPHA 1999
- BZUN 2007
- Country
- IPHA France
- BZUN China
- Employees
- IPHA N/A
- BZUN N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- BZUN Catalog/Specialty Distribution
- Sector
- IPHA Health Care
- BZUN Consumer Discretionary
- Exchange
- IPHA Nasdaq
- BZUN Nasdaq
- Market Cap
- IPHA 187.0M
- BZUN 166.3M
- IPO Year
- IPHA 2019
- BZUN N/A
- Fundamental
- Price
- IPHA $2.31
- BZUN $2.30
- Analyst Decision
- IPHA Strong Buy
- BZUN Buy
- Analyst Count
- IPHA 1
- BZUN 2
- Target Price
- IPHA $11.50
- BZUN $2.20
- AVG Volume (30 Days)
- IPHA 5.5K
- BZUN 240.5K
- Earning Date
- IPHA 09-12-2024
- BZUN 08-28-2024
- Dividend Yield
- IPHA N/A
- BZUN N/A
- EPS Growth
- IPHA N/A
- BZUN N/A
- EPS
- IPHA N/A
- BZUN N/A
- Revenue
- IPHA $68,134,188.00
- BZUN $1,235,027,314.00
- Revenue This Year
- IPHA N/A
- BZUN $5.22
- Revenue Next Year
- IPHA $105.84
- BZUN $5.32
- P/E Ratio
- IPHA N/A
- BZUN N/A
- Revenue Growth
- IPHA 6.88
- BZUN 5.56
- 52 Week Low
- IPHA $1.81
- BZUN $1.90
- 52 Week High
- IPHA $3.15
- BZUN $3.76
- Technical
- Relative Strength Index (RSI)
- IPHA 53.25
- BZUN 48.64
- Support Level
- IPHA $2.14
- BZUN $2.21
- Resistance Level
- IPHA $2.35
- BZUN $2.33
- Average True Range (ATR)
- IPHA 0.14
- BZUN 0.11
- MACD
- IPHA 0.00
- BZUN 0.01
- Stochastic Oscillator
- IPHA 61.76
- BZUN 62.07
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).